CashuKnight Therapeutics Inc. Secures $50 Million Credit Facility for Strategic Growth and Acquisitions20 days ago
CashuKnight Therapeutics Inc. Expands Portfolio with Exclusive Licensing Agreement with Sumitomo Pharmaabout 1 month ago
FinnHubTranscript : Knight Therapeutics Inc., Sumitomo Pharma America Holdings, Inc. - M&A Callabout 1 month ago
FinnHubKnight Therapeutics and Sumitomo Pharma Enter into Exclusive Licensing Agreements to Commercialize Sumitomo?S Canadian Portfolioabout 1 month ago
FinnHubKnight Therapeutics And Sumitomo Pharma Enter Into Exclusive Licensing Agreements To Commercialize Sumitomo'S Canadian Portfolioabout 1 month ago
FinnHubKnight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo’s Canadian Portfolioabout 1 month ago
FinnHubKnight Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 20252 months ago